Clinical Trials Logo

Recurrent Childhood Gliosarcoma clinical trials

View clinical trials related to Recurrent Childhood Gliosarcoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05857969 Recruiting - Clinical trials for Recurrent Childhood Acute Lymphoblastic Leukemia

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Start date: February 22, 2023
Phase:
Study type: Observational

Functional precision medicine (FPM) is a relatively new approach to cancer therapy based on direct exposure of patient- isolated tumor cells to clinically approved drugs and integrates ex vivo drug sensitivity testing (DST) and genomic profiling to determine the optimal individualized therapy for cancer patients. In this study, we will enroll relapsed or refractory pediatric cancer patients with tissue available for DST and genomic profiling from the South Florida area, which is 69% Hispanic and 18% Black. Tumor cells collected from tissue taken during routine biopsy or surgery will be tested.